Cure8 trial brief
The study tests a mental-health program adapted for people with IBD, comparing therapist-led versus self-directed online delivery — findings could influence access to psychosocial care options for patients with anxiety or depression.
Adults with Crohn's disease or ulcerative colitis experiencing moderate anxiety or depression; mental-health providers for IBD patients; researchers of psychosocial interventions and digital health.
The trial is recruiting at the Toronto Immune and Digestive Health Institute and plans to enroll about 100 adults (age 18–75) with Crohn’s disease or ulcerative colitis and GAD-7 and/or PHQ-9 scores in the 10–15 range.
Participants are randomized to 12 weekly sessions delivered by a social worker (50-minute sessions) versus 12 weekly online self-directed modules; outcomes focus on changes in anxiety (GAD-7) and depression (PHQ-9) at 3 months and time to improvement.
This is a trial registry entry describing study design, eligibility, and planned outcomes; it does not present results. Healing Circuits™ is described as a structured methodology in the record; efficacy and wider applicability will depend on trial findings.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Mental health symptoms are common in people with IBD and may be influenced by both psychological and biological factors. A virtual, group psychotherapy program tailored to IBD could increase access to treatment and help...
Stress and psychological distress are common in people with IBD and may influence symptoms and inflammation. This trial tests whether an 8‑week MBSR program can improve psychological wellbeing and whether those benefits...
Self‑management programs delivered by nurses may help people with IBD improve daily functioning, confidence in managing their condition, and quality of life even when inflammation markers don’t change. That matters...
